Senior Director, Medical Affairs Strategy & Launch--Hematology

Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website or follow us on LinkedIn. The Senior Director, Medical Strategy, Hematologic Malignancies & Launch Readiness reports to the VP of Medical Affairs and and is part of the Medical Affairs team. The role is responsible for supporting the development and execution of the medical affairs launch strategy for investigational and medical strategy for marketed hematology-oncology assets. This individual serves as a scientific and strategic leader within Medical Affairs, integrating external insights, clinical evidence, disease state knowledge, and cross-functional perspectives to deliver impactful medical initiatives across the product lifecycle. The role will work collaboratively with Field Medical, Clinical Development, Medical Communications, HEOR/RWE, Medical Information, Commercial, Regulatory, and other internal stakeholders to ensure a coordinated and scientifically rigorous approach to evidence generation, scientific exchange, and stakeholder engagement. A strong focus